Skip to content
healthcare.dev
Get a free key

HAVRIX

NDC 58160-825, Hepatitis A Vaccine, injection, suspension, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-825
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103475
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)720 [iU]/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Hepatitis A Vaccines [CS]; Inactivated Hepatitis A Virus Vaccine [EPC]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
58160-825-525816008255210 SYRINGE in 1 CARTON (58160-825-52) / .5 mL in 1 SYRINGE (58160-825-43)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-825 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.